Answer
Golimumab is contraindicated in moderate or severe heart failure (NYHA class III/IV).
Sources for this answer
- Simponi 50 mg solution for injection in pre filled syringeJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §4.3 Contraindications · Version 41Document updated
Sources checked